Universitätsklinikum Ulm

Hospital


Location: Ulm, Germany (DE) DE

ISNI: -

ROR: https://ror.org/05emabm63

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies (2022) Scherer M, Read C, Neusser G, Kranz C, Kuderna AK, Müller R, Full F, et al. Journal article The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C (2022) De Gregorio A, Janni W, Friedl TWP, Nitz U, Rack B, Schneeweiss A, Kates R, et al. Journal article COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S) (2022) Niess AM, Widmann M, Gaidai R, Goelz C, Schubert I, Castillo K, Sachs JP, et al. Journal article Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies (2022) Felgentreff K, Baumann U, Klemann C, Schuetz C, Viemann D, Wetzke M, Pannicke U, et al. Journal article Gender differences in Urologic training - results of the second GeSRU (Germany Society of Residents in Urology) training survey (2022) Siech C, Arnold H, Mattigk A, Bellut L, Koenig J, Kluth LA Conference contribution The impact of the COVID-19 pandemic on the mental health of medical staff considering the interplay of pandemic burden and psychosocial resources-A rapid systematic review (2022) Hannemann J, Abdalrahman A, Erim Y, Morawa E, Jerg-Bretzke L, Beschoner P, Geiser F, et al. Journal article, Review article Sick Leave and Intention to Quit the Job among Nursing Staff in German Hospitals during the COVID-19 Pandemic (2022) Schug C, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, et al. Journal article Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial (2022) Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Gjerga E, Hennig S, Schaper S, et al. Journal article Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial (2022) Gerber B, Schneeweiss A, Möbus V, Golatta M, Tesch H, Krug D, Hanusch C, et al. Journal article The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa) (2022) Eichler M, Singer S, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, et al. Journal article